Literature DB >> 2228823

A comparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fluorinated derivatives.

M Cannon1, S Harford, J Davies.   

Abstract

Chloramphenicol, thiamphenicol and three fluorinated derivatives, Sch 24893, Sch 25298 and Sch 25393, were studied with respect to inhibition of the growth of selected bacterial strains and cell-free translation systems. Thiamphenicol was the least potent inhibitor in the former experiments, but behaved similarly to chloramphenicol and Sch 25298 in the latter, thereby displaying selective inhibition of prokaryotic protein synthesis. Thiamphenicol and Sch 25298 were shown to be like chloramphenicol in inhibiting peptidyl transferase activity specifically on 70 S ribosomes, but the antibiotics bound to their common ribosomal-receptor site with different efficiencies in the order chloramphenicol greater than thiamphenicol greater than Sch 25298. Selected bacterial strains highly resistant to chloramphenicol and thiamphenicol because of chloramphenicol acetyltransferase production were, in contrast, highly sensitive to inhibition by the fluorinated antibiotics. Thus Sch 24893, Sch 25298 and Sch 25393 may have important uses in veterinary and clinical medicine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228823     DOI: 10.1093/jac/26.3.307

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  25 in total

1.  Nonenzymatic chloramphenicol resistance mediated by IncC plasmid R55 is encoded by a floR gene variant.

Authors:  A Cloeckaert; S Baucheron; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  In vitro and in vivo efficacy of florfenicol for treatment of Francisella asiatica infection in tilapia.

Authors:  Esteban Soto; Richard G Endris; John P Hawke
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

3.  Detection of florfenicol resistance genes in Escherichia coli isolated from sick chickens.

Authors:  K Keyes; C Hudson; J J Maurer; S Thayer; D G White; M D Lee
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Detection of multidrug-resistant Salmonella enterica serotype typhimurium DT104 based on a gene which confers cross-resistance to florfenicol and chloramphenicol.

Authors:  L F Bolton; L C Kelley; M D Lee; P J Fedorka-Cray; J J Maurer
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Plasmid-mediated florfenicol resistance encoded by the floR gene in Escherichia coli isolated from cattle.

Authors:  A Cloeckaert; S Baucheron; G Flaujac; S Schwarz; C Kehrenberg; J L Martel; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  Characterization of chloramphenicol resistance in beta-hemolytic Escherichia coli associated with diarrhea in neonatal swine.

Authors:  Kenneth M Bischoff; David G White; Patrick F McDermott; Shaohua Zhao; Stuart Gaines; John J Maurer; David J Nisbet
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Characterization of chloramphenicol and florfenicol resistance in Escherichia coli associated with bovine diarrhea.

Authors:  D G White; C Hudson; J J Maurer; S Ayers; S Zhao; M D Lee; L Bolton; T Foley; J Sherwood
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

8.  Animal-Use Antibiotics Induce Cross-Resistance in Bacterial Pathogens to Human Therapeutic Antibiotics.

Authors:  Atul K Singh; Arun K Bhunia
Journal:  Curr Microbiol       Date:  2019-07-25       Impact factor: 2.188

9.  Tissue pharmacokinetics of florfenicol in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jian-Zhong Li; Ki-Fai Fung; Zhang-Liu Chen; Zhen-Ling Zeng; Jie Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Oct-Dec       Impact factor: 2.441

10.  Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jianzhong Liu; Ki-Fai Fung; Zhangliu Chen; Zhenling Zeng; Jie Zhang
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.